Nebacumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nebacumab
Monoclonal antibody
Type Whole antibody
Source Human
Target endotoxin
Clinical data
AHFS/Drugs.com International Drug Names
ATC code
Identifiers
CAS Number
ChemSpider
  • none
KEGG
 NYesY (what is this?)  (verify)

Nebacumab is a human monoclonal antibody developed for the treatment of sepsis.[1] It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.[2]

References[edit]

  1. ^ Derkx, B.; Wittes, J.; McCloskey, R. (1999). "Randomized, Placebo‐Controlled Trial of HA‐1A, a Human Monoclonal Antibody to Endotoxin, in Children with Meningococcal Septic Shock". Clinical Infectious Diseases. 28 (4): 770–726. PMID 10825037. doi:10.1086/515184. 
  2. ^ WHO: Consolidated List of Products